Table 2.
Top reported comorbidities and medications associated with deaths following COVID-19 vaccination by the location of vaccination.
| All locations N = 55 | Long-term care facilities N = 37 | Other locations N = 18 | P | ||||
|---|---|---|---|---|---|---|---|
| N | % | N | % | N | % | ||
| Comorbidities | |||||||
| Hypertension | 22 | 40.0 | 14 | 37.8 | 8 | 44.4 | 0.6390 |
| Dementia | 17 | 30.9 | 15 | 40.5 | 2 | 11.1 | 0.0267 |
| COPD | 13 | 23.6 | 9 | 24.3 | 4 | 22.2 | 1.0000 |
| Diabetes | 12 | 21.8 | 7 | 18.9 | 5 | 27.8 | 0.4993 |
| Heart failure | 10 | 18.2 | 9 | 24.3 | 1 | 5.6 | 0.1399 |
| Hyperlipidemia | 9 | 16.4 | 6 | 16.2 | 3 | 16.7 | 1.0000 |
| Anemia | 8 | 14.5 | 7 | 18.9 | 1 | 5.6 | 0.2497 |
| CKD | 7 | 12.7 | 4 | 10.8 | 3 | 16.7 | 0.6713 |
| Stroke | 7 | 12.7 | 5 | 13.5 | 2 | 11.1 | 1.0000 |
| Atrial fibrillation | 6 | 10.9 | 5 | 13.5 | 1 | 5.6 | 0.6514 |
| Depression | 6 | 10.9 | 5 | 13.5 | 1 | 5.6 | 0.6514 |
| Fall | 6 | 10.9 | 6 | 16.2 | 0 | 0.0 | 0.1621 |
| GERD | 6 | 10.9 | 4 | 10.8 | 2 | 11.1 | 1.0000 |
| Medications | |||||||
| Acetaminophen | 9 | 16.4 | 8 | 21.6 | 1 | 5.6 | 0.2441 |
| Aspirin | 9 | 16.4 | 6 | 16.2 | 3 | 16.7 | 1.0000 |
| Amlodipine | 8 | 14.5 | 6 | 16.2 | 2 | 11.1 | 0.7079 |
| Metoprolol | 8 | 14.5 | 6 | 16.2 | 2 | 11.1 | 0.7079 |
| Omeprazole | 7 | 12.7 | 6 | 16.2 | 1 | 5.6 | 0.4058 |
| Potassium | 6 | 10.9 | 6 | 16.2 | 0 | 0.0 | 0.1621 |
| Vitamin D | 6 | 10.9 | 6 | 16.2 | 0 | 0.0 | 0.1621 |
| Docusate | 5 | 9.1 | 5 | 13.5 | 0 | 0.0 | 0.1603 |
| Furosemide | 5 | 9.1 | 5 | 13.5 | 0 | 0.0 | 0.1603 |
| Lisinopril | 5 | 9.1 | 4 | 10.8 | 1 | 5.6 | 0.6583 |
| Mirtazapine | 5 | 9.1 | 4 | 10.8 | 1 | 5.6 | 0.6583 |
| Tamsulosin | 5 | 9.1 | 3 | 8.1 | 2 | 11.1 | 1.0000 |
COVID-19, coronavirus disease 2019; COPD, chronic obstructive pulmonary disease; CKD, chronic kidney disease; GERD, gastroesophageal reflux disease.